Influence of mechanical ventilation on the pharmacokinetics of vancomycin administered by continuous infusion in critically ill patients
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Pathophysiological changes involved in drug disposition in critically ill patients should be considered in order to optimize the dosing of vancomycin administered by continuous infusion, and certain strategies must be applied to reach therapeutic targets on the first day of treatment. The aim of this study was to develop a population pharmacokinetic model of vancomycin to determine clinical covariates, including mechanical ventilation, that influence the wide variability of this antimicrobial. Plasma vancomycin concentrations from 54 critically ill patients were analyzed simultaneously by a population pharmacokinetic approach. A nomogram for dosing recommendations was developed and was internally evaluated through stochastic simulations. The plasma vancomycin concentration-versus-time data were best described by a one-compartment open model with exponential interindividual variability associated with vancomycin clearance and the volume of distribution. Residual error followed a homoscedastic trend. Creatinine clearance and body weight significantly dropped the objective function value, showing their influence on vancomycin clearance and the volume of distribution, respectively. Characterization based on the presence of mechanical ventilation demonstrated a 20%25 decrease in vancomycin clearance. External validation (n 18) was performed to evaluate the predictive ability of the model; median bias and precision values were 0.7 mg/liter (95%25 confidence interval [CI], 0.4, 1.7) and 5.9 mg/liter (95%25 CI, 5.4, 6.4), respectively. A population pharmacokinetic model was developed for the administration of vancomycin by continuous infusion to critically ill patients, demonstrating the influence of creatinine clearance and mechanical ventilation on vancomycin clearance, as well as the implications for targeting dosing rates to reach the therapeutic range (20 to 30 mg/liter). © 2017 American Society for Microbiology. All Rights Reserved.
publication date
funding provided via
published in
Research
keywords
-
Dosing recommendations; Intensive care; Mechanical ventilation; Population pharmacokinetics; Stochastic simulations; Vancomycin catecholamine; creatinine; furosemide; nonsteroid antiinflammatory agent; vancomycin; antiinfective agent; creatinine; vancomycin; adult respiratory distress syndrome; aged; APACHE; Article; artificial ventilation; body weight; compartment model; concentration at steady-state; continuous infusion; creatinine blood level; creatinine clearance; critically ill patient; dose calculation; drug blood level; drug clearance; drug targeting; female; human; infusion rate; kidney function; loading drug dose; major clinical study; male; measurement precision; medical record review; multiple organ failure; nomogram; pharmacokinetic parameters; plasma concentration-time curve; pneumonia; priority journal; retrospective study; septic shock; stochastic model; volume of distribution; blood; critical illness; drug monitoring; intensive care unit; intravenous drug administration; metabolism; Aged; Anti-Bacterial Agents; Creatinine; Critical Illness; Drug Monitoring; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Nomograms; Respiration, Artificial; Vancomycin
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue